Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study) - Isaacson, S; Eggert, K; Kumar, R (Journal of the Neurological Sciences, 2017)
et al.